Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 15Pain 13Pain, Postoperative 12Depression 9Breast Neoplasms 9Agnosia 9Head and Neck Neoplasms 6Anxiety Disorders 6Chronic Pain 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Acute Pain 4Pancreatic Neoplasms 3Pain, Intractable 3Lymphoma, Follicular 3Colorectal Neoplasms 3Prostatic Neoplasms 2Mucositis 2Gastrointestinal Neoplasms 2Colonic Neoplasms 2Cancer Pain 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Stomatitis 1Spinal Stenosis 1Sezary Syndrome 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Analgesia 1Polycythemia Vera 1

Interventions

Saline Solution 1Ketamine 1Electroencephalography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Otolaryngeal Cancer × Ketamine × Clear all
NCT03040024 2021-07-08

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Emory University

Phase 4 Terminated
71 enrolled 17 charts
Head & Neck

Otolaryngeal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡